Atlas Trials

Stage IV Esophageal Cancer AJCC v7

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Esophageal Cancer AJCC v7

RecordFirmDate
CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors (NCT02757391)M.D. Anderson Cancer Center2019-08-09
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer (NCT03161522)M.D. Anderson Cancer Center2018-02-19
Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery (NCT03008278)National Cancer Institute (NCI)2018-02-06
Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer (NCT03196232)George Albert Fisher2017-09-13
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy (NCT02381561)National Cancer Institute (NCI)2016-02-01
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer (NCT01142388)National Cancer Institute (NCI)2010-09-21

Track Stage IV Esophageal Cancer AJCC v7 automatically

Every clearance here is in the API, with alerts when new ones post.